May 03, 2019
3 min watch
Save

VIDEO: Encapsulated cell therapy shows promising results in MacTel and glaucoma

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SAN DIEGO  At the Ophthalmology Innovation Summit, Rich Small, CPA, CEO of Neurotech Pharmaceuticals, discusses the company’s encapsulated cell therapy’s progress in clinical trials for macular telangiectasia as well as neuroprotection in glaucoma.